Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at basel...
Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Thoracic Society
Subjects
More information
Scope and Contents
Contents
Several clinical trials have demonstrated that anti-IL-5(R) biologics were able to improve lung function, asthma control and chronic oral corticosteroid exposure and reduce exacerbations among eosinophilic asthmatic patients. However, a certain variability in clinical responses to anti-IL-5(R) biologics was brought to light. Our study aimed at eval...
Alternative Titles
Full title
Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10715510
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10715510
Other Identifiers
ISSN
0040-6376,1468-3296
E-ISSN
1468-3296
DOI
10.1136/thorax-2022-219781
